NCT06880575 Seniors Integrated Longitudinal cardioVascular Evaluation of Coronary Heart Disease: a Multicenter, Prospective Registry in China (SILVER-China)
| NCT ID | NCT06880575 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Hospital |
| Condition | Coronary Arterial Disease (CAD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,139 participants |
| Start Date | 2024-11-06 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,139 participants in total. It began in 2024-11-06 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to establish a nationwide cohort and biobank of elderly patients with coronary heart disease (CHD) and to develop risk prediction models and clinical treatment optimization plans based on this data. The specific research content is as follows: The Study plan to continuously enroll hospitalized elderly CHD patients across 50 centers nationwide. Using networked electronic data collection technology, standardized methods and protocols will be used to gather demographic information (such as age, gender, education level, income, etc.), clinical information (medical history, past treatment records, current treatment plans, surgical records, medication use, etc.), lifestyle information (dietary habits, exercise frequency, smoking, drinking, etc.), biological information (such as inflammatory markers, etc.), and physical examination data (such as blood pressure, ECG, sleep monitoring, imaging examinations, etc.). These patients will be followed up long-term (1 month, 6 months, 1 year, and annually thereafter for up to 5 years) to establish a database that meets international standards. Centers meeting the criteria will also retain biological samples, creating a multicenter biobank for elderly CHD patients. Second, based on the established clinical cohort, a risk prediction model for elderly CHD patients will be developed, including mortality risk, ischemic risk, bleeding risk, etc. Additionally, optimized clinical diagnostic and treatment plans will be formulated to improve the treatment outcomes and quality of life for elderly CHD patients. This research is expected to provide scientific evidence and technical support for the prevention, diagnosis, and treatment of CHD in elderly patients.
Eligibility Criteria
Inclusion Criteria: ① Age requirements: Participants are ≥ 75 years old; * This time he was admitted to the hospital due to angina pectoris and other coronary heart disease-related symptoms ③ Conform to the diagnosis of coronary heart disease: meet any one of the following conditions: 1. This admission was performed for coronary angiography, coronary artery CTA confirmed coronary heart disease; 2. Previous clear coronary angiography, coronary artery Coronary heart disease diagnosed by imaging evidence such as CTA evidence; 3. The attending physician according to the patient's symptoms, medical history, myocardial injury markers, electrocardiogram, echo cardiography, myocardial radionuclide imaging, etc. diagnosed coronary heart disease. ④ Informed consent: Participants must be able to understand the content of the study, voluntarily participate in the study, and sign the informed consent form. Exclusion Criteria: * Combined with severe non-cardiovascular disease: life expectancy does not exceed 6 months, such as advanced cancer or other end-stage disease; * Unable to cooperate with long-term follow-up: such as patients with severe cognitive impairment or severe mental illness; ③ Non-cardiogenic death within 24 hours after admission.
Frequently Asked Questions
Who can join the NCT06880575 clinical trial?
This trial is open to participants of all sexes, aged 75 Years or older, studying Coronary Arterial Disease (CAD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06880575 currently recruiting?
Yes, NCT06880575 is actively recruiting participants. Visit ClinicalTrials.gov or contact Beijing Hospital to inquire about joining.
Where is the NCT06880575 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06880575 clinical trial?
NCT06880575 is sponsored by Beijing Hospital. The trial plans to enroll 10,139 participants.